RecruitingPhase 3NCT06366464
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Harmony Biosciences Management, Inc.
- Intervention
- Pitolisant tablet(drug)
- Enrollment
- 134 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2024 – 2027
Study locations (30)
- Santa Monica Clinical Trials, Los Angeles, California, United States
- Center of Excellence in Diabetes and Endocrinology, Sacramento, California, United States
- Rady Children's Hospital - Scan Diego, San Diego, California, United States
- Colorado Children's Hospital, Aurora, Colorado, United States
- Nemours Children's Hospital, Wilmington, Delaware, United States
- Atlanta Diabetes Associates, Atlanta, Georgia, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- Rare Disease Research, Atlanta, Georgia, United States
- Ann And Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Riley Children's Hospital, Indianapolis, Indiana, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Mayo Clinic-PPDS, Rochester, Minnesota, United States
- Maimonides Medical Center, Brooklyn, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- Science 37 (at-home option), Morrisville, North Carolina, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06366464 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06420297OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06144645A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSFoundation for Prader-Willi Research
- ACTIVE NOT RECRUITINGPHASE3NCT06173531Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.